Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-07-30

Clinical Trial Update: Safety and Efficacy Study of Lotus Valve for Transcatheter Aortic Valve Replacement [NA]

View source ↗

Summary

Clinical trial update for the Lotus Valve in transcatheter aortic valve replacement (TAVR) shows terminated status with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lotus Valve

Snippet

Sponsor: Boston Scientific Corporation | Conditions: Aortic Stenosis | NA | Status: TERMINATED | Results posted: 2019-07-30